Cargando…

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy

T-cell recognition of somatic mutation-derived cancer neoepitopes can lead to tumor regression. Due to the difficulty to identify effective neoepitopes, constructing a database for sharing experimentally validated cancer neoantigens will be beneficial to precise cancer immunotherapy. Meanwhile, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Jiaqi, Bai, Peng, Fan, Weiliang, Li, Qiming, Li, Yongzheng, Wang, Dehe, Yin, Lei, Zhou, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078594/ https://www.ncbi.nlm.nih.gov/pubmed/33927717 http://dx.doi.org/10.3389/fimmu.2021.644637

Ejemplares similares

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023)

Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
por: Morisaki, Shinji, et al.
Publicado: (2023)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017)

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017)

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
por: Wickström, Stina L., et al.
Publicado: (2019)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

The neoepitope landscape of breast cancer: implications for immunotherapy
por: Narang, Pooja, et al.
Publicado: (2019)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
por: Bai, Peng, et al.
Publicado: (2021)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
por: Shou, Jiawei, et al.
Publicado: (2022)

Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
por: de Sousa, Eric, et al.
Publicado: (2021)

Circular RNAs as a potential source of neoepitopes in cancer
por: Xia, Jiaqi, et al.
Publicado: (2023)

Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy
por: Wu, Tao, et al.
Publicado: (2023)

Cancer neoantigens as potential targets for immunotherapy
por: Ma, Weijie, et al.
Publicado: (2021)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)

The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017)

Neoantigens and NK Cells: “Trick or Treat” the Cancers?
por: Lv, Dan, et al.
Publicado: (2022)

Designing neoantigen cancer vaccines, trials, and outcomes
por: Biswas, Nupur, et al.
Publicado: (2023)

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2018)

The Value of Microbes in Cancer Neoantigen Immunotherapy
por: Tian, Junrui, et al.
Publicado: (2023)

A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations
por: Toor, Jugmohit S., et al.
Publicado: (2018)

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2021)

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature
por: Riba, Marta, et al.
Publicado: (2021)

Computational Prediction and Validation of Tumor-Associated Neoantigens
por: Roudko, Vladimir, et al.
Publicado: (2020)

A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy
por: Xu, Bingxiang, et al.
Publicado: (2021)

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
por: Wei, Zhiting, et al.
Publicado: (2019)

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)

Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report
por: Liu, Chenxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_op3qmel3bul02c94namdtnlrqg